United Therapeutics CEO Martine A. Rothblatt reports $5.13 million common share sale
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 14, 2026, at prices ranging from $526.07 to $546 per share.
1. Share sale
Rothblatt exercised 9,500 stock options at $117.76 per share. After the transactions, 233,410 options remained held indirectly through a trust, and the transacting trusts held 324,443 common shares.
